D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial. (26th September 2015) - Cecere, S.C.; Daniele, G.; Lorusso, D.; Scambia, G.; Nicoletto, M.O.; Breda, E.; Colombo, N.; Artioli, G.; Daniele, B.; Lo Re, G.; Raspagliesi, F.; Chiappa, V.; et al.